People with diabetes are at risk of developing diabetic retinopathy (DR), a condition that can eventually cause blindness, but manual screening for DR is inefficient, given how large the at-risk population is. The solution, according to a recent large-scale U.K. study, is automation.

Theranos Inc. was back in the news Thursday, this time with word that one of its top executives who has received intense scrutiny is retiring.